The Joint Corp. (JYNT)
NASDAQ (CM) NASDAQ (CM) Primary 
Shareholders of Joint Stock Company Kaspi.kz Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KSPI
NEW YORK CITY, NY / ACCESSWIRE / January 7, 2025 / WHY: New York, N.Y., January 7, 2025.
Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Joint Stock Company Kaspi.kz Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Joint Stock Company Kaspi.kz Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor
On Monday, CytoMed Therapeutics GDTC stock is down 6.35% at $3.23 at last check Monday.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Joint Stock Company Kaspi.kz Class Action: Levi & Korsinsky Reminds Joint Stock Company Kaspi.kz Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - KSPI
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kz - KSPI
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Joint Stock Company Kaspi.kz ("Kaspi.kz" or the "Company") (NASDAQ:KSPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Joint Stock Company Kaspi.kz Lawsuit - KSPI
NEW YORK, NY / ACCESSWIRE / January 5, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
